Opinion
SUMMARY
A shаreholder in a company acquired in a merger transaction sued the law firm which represented the acquiring company for fraud. He alleged the law firm concealed
FACTUAL AND PROCEDURAL BACKGROUND
Frank T. Vega (Vega), a 23 percent shareholder in a company known as Monsterbook.com, sued Jones, Day, Reavis & Pogue (Jones Day), a law partnership, for fraud and negligent misrepresentation in connection with a merger transaction. In the merger transaction, Jones Day represented Transmedia Asia Pacific, Inc., which acquired Monsterbook. Monsterbook and Vega were represented by the law firm of Heller, Ehrman, White & McAuliffe (Heller Ehrman).
The terms of the acquisition included Vega’s receipt of restricted stock in Transmedia in exchange for his interest in Monsterbook. Monsterbook and Vega accepted the mergеr offer on March 8, 2000. Closing occurred on April 13, 2000, when the two companies exchanged stock based on a $15 million valuation of Monsterbook. Vega thus exchanged stock valued at $3.45 million for the restricted Transmedia stock.
During the weeks between Vega’s acceptance of the merger offer on March 8 and the closing on April 13, Transmedia, which “[everybody knew . . . was an iffy company,” sought and secured $10 million in investment financing from a third party. 1 The terms of Transmedia’s $10 million third party financing transaction included so-called toxic stock provisions, under which the investors received convertible preferred stock that seriously diluted the shares of all other Transmedia stockholders. Both Transmedia and Jones Day knеw that “toxic” stock financing is a “desperate and last resort of financing for a struggling company” and that 95 percent of companies who engage in such financing end up in bankruptcy.
Jones Day prepared a two-page disclosure schedule that clearly described and properly disclosed the “toxic” provisions of the $10 million investment, but did not send the disclosure to Vega, Monsterbook or Heller Ehrman. Jones Day knew that a full disclosure of the “toxic” terms of the financing would have “killed the acquisition,” without which Transmedia would not have obtained the financing and would have gone out of business. Instead, Vega, Monsterbook and Heller Ehrman were told, on about March 16, 2000, that the $10 million financing then being negotiated wаs “standard” and “nothing unusual” and that Jones Day and Transmedia would supply additional documents to support these characterizations of the financing.
2
Jones Day also prepared, and Transmedia sent to Monsterbook and Vega, a consent form concerning the $10 million investment, which Vega signed. The consent form stated that the $10 million investment would be convertible into an aggregate maximum of 6,815,000 shares of common stock, “thus misrepresenting that it fell within the 20% dilution ‘toxic’ cap mandated by NASD Rule 4350(i)(l)(D).” On March 28, 2000, two weeks before the closing of Transmedia’s acquisition of Monsterbook, Jones Day filed a “Certificate of Designation” with the Delaware Secretary of State, certifying the creation of the convertible preferred stock. This document, available to the public, contained all the terms of the financing, including the “toxic” provisions.
The closing of the Monsterbook acquisition occurred on April 13, 2000. Eight months later, on December 14, 2000, Vega learned for the first time, through a press release issued by Transmedia, about the “toxic” stock provision of the $10 million financing. Several legal actions ensued.
First, on October 2, 2001, Monsterbook’s former majority shareholder, William H. McKee, who had owned 70.125 percent of Monsterbook’s stock, sued Heller Ehrman for legal malpractice. In a first amended complaint on November 21, 2001, McKee and a second shareholder, Paul R. Estrada, who had held a 1.486 percent interest in Monsterbook, also named Transmedia and Jones Day as defendants, alleging causes of action for fraud and negligent misrepresentation.
Second, on December 14, 2001, another shareholder, John Cuero, who had held a 2 percent interest in Monsterbook, sued Heller Ehrman, Jones Day, and Transmedia. This suit was consolidated with McKee’s lawsuit. In the consolidated actions, Jones Day sought and obtained summary judgment, and judgment was entered in its favor on August 23, 2002. 3 Estrada waived his right to appeal; McKee abandoned his appeal; and Cuero’s appeal was dismissed at his request.
— The claim did not allege an actionable, affirmative misstatement by Jones Day;
— Vega could not justifiably have relied on the statements allegedly made by Jones Day;
— Because Jones Day owed Vega no duty to disclose, Vega could not state a claim based on omission or nondisclosure;
— Vega did not allege damages proximately caused by Jones Day;
— Vega had no standing to bring the claim because it was derivative in nature;
— The claim was barred by the statute of limitations; and
— The claim was barred by res judicata.
Jones Day’s demurrer to the negligent misrepresentation сlaim was sustained on the same grounds and, in addition, because a negligent misrepresentation claim cannot be based on an omission or nondisclosure. The court also concluded Vega failed to plead both causes of action with the requisite specificity.
The trial court’s order sustaining the demurrers and dismissing Vega’s complaint with prejudice was filed August 5, 2003, and this appeal followed. 5
DISCUSSION
Vega’s allegations may be summarized as follows. Jones Day hid the existence of the “toxic” stock provisions with the intent to induce Vega to give up his valuable stock in Monsterbook in exchange for Transmedia’s “toxic” and worthless stock. Jones Day knew about the “toxic” stock provisions, and knew the acquisition would not oсcur if Monsterbook, Vega and their lawyers discovered them. Jones Day deliberately concealed the “toxic” stock provisions by telling Heller Ehrman the transaction was “standard” and “nothing unusual,” by failing to provide the proper written disclosure it prepared, and by instead providing a different, sanitized version of the disclosure. Vega did not know, and had no reason to suspect, that the financing contained “toxic” provisions, and would not have given up his valuable stock in Monsterbook had he known. As a result of Jones Day’s concealment of the “toxic” terms of the financing, Vega lost his $3.45 million interest in Monsterbook.
We agree with Vega that the complaint properly states a fraud claim.
Before we analyze the elements of the claim, we note the governing legal principles.A fraud claim against a lawyer is no different from a fraud claim against anyone else. “ ‘If an attorney commits actual fraud in his dealings with a third party, the fact he did so in the capacity of attorney for a client does not relieve him
With these principles in mind, we turn to the elements of fraud, which are: “(1) representation; (2) falsity; (3) knowledge of falsity; (4) intent to deceive; and (5) reliance and resulting damage (causation).” (5 Witkin, Cal. Procedure (4th ed. 1997) Pleading, § 668, p. 123.) Active concealment or suppression of facts by a nonfiduciary “is the equivalent of a false representation, i.e., actual fraud.” (Id., § 678, p. 136, italics omitted.) We treat the various elements, and the bases for the trial court’s decision, in turn.
1. False representation.
We agree with Jones Day that a mere statement that the $10 million financing then being negotiated wаs “standard” and “nothing unusual” is not itself an actionable misrepresentation. While expressions of professional opinion are sometimes treated as representations of fact, a “casual expression of belief’ is not similarly treated.
(Bily
v.
Arthur Young & Co.
(1992)
More problematic, however, is the question of active concealment or suppression of facts, which is the equivalent of a false representation. Vega alleges that Jones Day, after telling Heller Ehrman that Transmedia was about to close a $10 million private stock transaсtion which it wanted to include in its disclosure schedules, prepared a proper disclosure schedule containing the pertinent terms, but provided a “different sanitized version” of the schedule, without the “toxic” stock provisions. Thus, Vega alleges that Jones Day “deliberately or with a reckless disregard of the truth concealed the ‘toxic’ stock provisions” from Vega, Monsterbook and Heller Ehrman. These allegations state an “active concealment or suppression of facts.”
7
(5 Witkin, Cal. Procedure,
Jones Day contends that fraud based on concealment requires that the defendant have a duty to disclose the suppressed fact, and that as counsel for the adverse party in a merger, Jones Day owed no duty to disclose to Vega or Monsterbook the terms of the third party $10 million investment. Thus, the disclosure schedule, they contend, “is entirely irrelevant” because Jones Day had no duty to provide it to Monsterbook or Vega or Heller Ehrman. We disagree. Jones Day specifically undertook to disclose the transaction and, having done so, is not at liberty to conceal a material term. Even where no duty to disclose would otherwise exist, “where one does speak he must speak the whole truth to the end that he does not conceal any facts which materially qualify those stated. [Citation.] One who is asked for or vоlunteers information must be truthful, and the telling of a half-truth calculated to deceive is fraud.”
(Cicone v. URS Corp., supra,
Jones Day insists this case is controlled by
B.L.M. v. Sabo & Deitsch
(1997)
B.L.M.
is entirely inapposite. First, plaintiff B.L.M.’s claims were grounded solely in professional negligence—not fraud. On appeal, B.L.M. argued it should be permitted to proceed against the attorneys under a theory of negligent misrepresentation—not fraud. The court reviewed that contention, and ultimately concluded B.L.M. failed to sufficiently allege that the lawyers had the intent to induce BJL.M.’s reliance on their representations, or that the reliance of B.L.M. was justifiable “under the circumstances of the case.”
{B.L.M., supra,
Jones Day contends that
Shafer
is irrelevant, and suggests the result there was due to “the peculiar circumstances.” In
Shafer,
the court held that an attorney, who was retained by an insurance company to provide coverage advice in a lawsuit against its insured, could be held liable to the plaintiffs in that lawsuit for making a fraudulent statement about coverage.
(Shafer, supra,
2. Justifiable reliance.
Jones Day argues that publicly available information cannot form the basis for a concealment claim, and Vega, with reasonable diligence, could have known about the “toxic” stock provisions. Jones Day points out that Vega had notice, in the consent form he signed, that a “Certificate of Designation” regarding the $10 million investment and its terms would be filed with the Delaware Secretary of State at some time in the future, and that this certificate, containing all the financing terms, was in fact filed two weeks before the merger closed. 10
Jones Day’s argument fails on two counts. First, the contention that publicly available information cannot form the basis for а concealment claim is mistaken. The mere fact that information exists somewhere in the public domain is by no means conclusive. (See, e.g.,
Seeger v. Odell
(1941)
3. Reliance and causation.
Jones Day argues Vega cannot establish that nondisclosure of thе “toxic” terms of the $10 million third party financing resulted in any damage. This is because (1) Vega agreed to exchange his Monsterbook stock for Transmedia stock on March 8, 2000, before the third party financing transaction arose and before he consented to it, and (2) Vega “concedes” in his complaint that Transmedia “would have gone out of business” without the $10 million investment. This claim is puzzling at best. First, while Vega agreed to exchange his stock on March 8, he may have had good grounds to rescind the agreement if the “toxic” terms of the financing had been disclosed. This is not a point that can be determined on a demurrer. Second, Jones Day quotes only part of the sentence in which Vega “concedes” Transmedia would have gone out of business without the financing. The complaint alleges that disclosure of the “toxic” terms of the financing “would have killed the acquisition,” and that “[without the acquisition,” Transmedia would not have obtained the financing and would have gone out of business. We fail to see how these allegations show Vega was not harmed by the failure to disclose the “toxic” terms of the financing. Quite the contrary. Vega alleges that had full disclosure been made, he would not have exchanged his valuable Monsterbook stock for the “toxic” Transmedia stock. Those allegations, if true, show the nondisclosure resulted in damage.
4. Requisite particularity.
The trial court also sustained the demurrer on the ground Vega failed to allege the cause оf action “with the requisite degree of specificity.” Jones Day argues Vega has not alleged “(1) who, (2) said what, (3) to whom, (4) when, and (5) in what manner,” and waived the opportunity to replead.
12
Again we disagree. The pertinent question in a concealment case is not who said what to whom; the question, among others, is whether Jones Day, in undertaking to disclose the $10 million financing, intentionally concealed its “toxic” terms from Vega and Monsterbook so that they would proceed with the transaction. The complaint sufficiently apprises Jones Day of the facts of Vega’s fraud claim to allow Jones Day to prepare its defense. (See
Committee on Children’s Television, Inc.
v.
General Foods Corp.
(1983)
5. Standing to sue.
Jones Day contends Vega has no standing to sue Jones Day for fraud because his claims are “derivative” claims. In a tortuous argument, Jones Day concludes that because Vega agreed to accept Transmedia stock before the
third party financing transaction arose, the gravamen of his complaint “must be for the diminution in
Jones Day is mistaken. A derivative suit is a suit brought on behalf of a corporation for injury to the corporation, often for breach of fiduciary duty, mismanagement or other wrongdoing by corporate officers or directors, or for wrongs against the corporation by third parties. (See Friedman, Cal. Practice Guide: Corporations (The Rutter Group 2004) f| 6:602 & 6:603, pp. 6-128.1 to 6-128.2.) An action is derivative “ ‘if the gravamen of the complaint is injury to the corporation, or to the whole body of its stock and property without any severance or distribution among individual holders, or it seeks to recover assets for the corporation or to prevent the dissipation of its assets.’ ”
(Jones
v.
H.F Ahmanson & Co.
(1969)
6. Statute of limitations.
Jones Day argues that Vega’s fraud claim is barred by the three-year statute of limitations. 14 Again, we disagree.
Vega alleged he first discovered the “toxic” terms of the $10 million financing transaction on December 14, 2000, when a Transmedia press release revealed that the terms of the financing had included a “toxic” stock provision. He filed suit on May 12, 2003. Jones Day argues the three-year statute expired no later than March 28, 2003, three years after the filing in Delaware of the “Certificate of Designation” containing all the terms of the transaction. Jones Day recognizes that the stаtute of limitations in a fraud action does not begin to run “until the discovery, by the aggrieved party, of the facts constituting the fraud . . . .” (Code Civ. Proc., § 338, subd. (d).) However, it argues Vega should have discovered the “toxic” terms of the financing on March 28, 2000, since the filing of the certificate in Delaware put him on inquiry notice.
7. Res judicata.
Finally, Jones Day contends that Vega’s claims are barred by the doctrine of res judicata, because Jones Day obtained summary judgment in its favor on fraud claims in earlier lawsuits brought by three other shareholders, who subsequently waived, abandoned and dismissed their respective appeals. Jones Day argues Vega was in privity with each of those three shareholders, because he is also a former shareholder in Monsterbook, his fraud claim is the same as their claims, he knew about their lawsuits, and he is using the same attorney. This relationship, Jones Day contends, is sufficiently close to justify application of the principle of preclusion. Again, we cannot agree.
The doctrine of res judicata precludes parties or their privies from relitigating issues decided in a prior action in which a final judgment on the merits was entered. While Jones Day obtained summary judgment on fraud claims by three other shareholders, Vega was not a party to those lawsuits. The concept of privity has been expanded to include “a relationship betweеn the party to be estopped and the unsuccessful party in the prior litigation which is ‘sufficiently close’ so as to justify application of the doctrine of collateral estoppel.”
(Clemmer
v.
Hartford Ins. Co.
(1978)
We discern no basis for concluding Vega “should reasonably havе expected to be bound by” the adjudication of lawsuits in which he did not participate in any way, in which he had no proprietary or financial interest, and over which he had no control
DISPOSITION
The order dismissing the complaint, construed as a judgment of dismissal, is reversed and the cause is remanded for further proceedings. Appellant is entitled to recover his costs on appeal.
Cooper, P. J., and Rubin, J., concurred.
A petition for a rehearing was denied August 30, 2004, and respondent’s petition for review by the Supreme Cоurt was denied October 27, 2004. Chin, J., was of the opinion that the petition should be granted.
Notes
Transmedia’s Form 10-K annual report for fiscal year 1998, filed with the Securities and Exchange Commission, indicated Transmedia’s working capital deficit raised “substantial doubt about its ability to continue as a going concern,” and that its ability to do so was dependent on its ability to continue to effect sales of equity securities and issue of debt. Its annual report for fiscal year 1999, filed January 13, 2000, showed a slightly larger working capital deficit, decreased revenues and an increased net loss.
On March 16, 2000, Heller Ehrman sent an e-mail informing Monsterbook and Vega as follows: “On another note, I received a call from the lawyers for Transmedia. . . . There are a couple of disclosure issues relating to Transmedia that came up. Specifically, they are revising their most recent 10K (annual report) and are also about to close a private stock financing. Neither of these were included in the disclosure schedules that they sent to us, and they want them included—which means that they have to wait until they sort out their books. I have not spoken directly with their attorneys, we’ve just traded phone messages. Tom Stromberg who has been working on this deal also gave them a call. Neither we nor Transmedia’s attorneys think that this is a big deal as it relates to the MonsterBook acquisition, but it will delay closing.”
The complaint in McKee’s lawsuit, unlike Vega’s complaint, did not allege that Jones Day prepared a complete disclosure of the $10 million financing, but provided Heller Ehrman with a sanitized version of the disclosure schedule without the toxic stock provisions. The trial court in the McKee case (Judge James C. Chalfant) concluded that: (1) Jones Day’s statements that the preferred stock offering was “no big deal” and “standard” were nonactionable expressions of opinion. Because Jones Day’s loyalty was owed only to Transmedia, not to Monsterbook’s shareholders, Jones Day had no duty to disclose the details of the transaction. The statement was also nonactionable because of its casual nature, so that it could not be relied on by anyone. (2) The consеnt form prepared by Jones Day and signed by Transmedia and McKee was not a representation by Jones Day; and there was no evidence that the consent form—concerning the aggregate maximum of 6,815,000 shares—was a misrepresentation or a misleading half-truth. Therefore, Jones Day had no duty to disclose other terms of the preferred stock transaction. (3) McKee and the other shareholders could not have justifiably relied on Jones Day’s opinions; any reliance on Jones Day’s opinion that the transaction was “standard” or “no big deal” would have been unreasonable as a matter of law.
Transmedia’s default was entered on October 2, 2003.
The trial court’s order dismissed Vega’s complaint with prejudice, but no judgment was entered for Jones Day in аccordance with the order. Since the case is fully briefed, in the interests of judicial economy we will construe the order as a judgment of dismissal. (See
Smith v. Hopland Band of Pomo Indians
(2002)
The demurrer to Vega’s cause of action for negligent misrepresentation was properly sustained by the trial court, since such a claim requires a positive assertion.
(Wilson v. Century 21 Great Western Realty
(1993)
See Civil Code sections 1710, subdivision 3 (defining deceit as including “[t]he suppression of a fact, by one who is bound to disclose it, or who gives information of other facts which are likely to mislead for want of communication of that fact”), and 1572, subdivision 3 (defining actual fraud in a contract setting to include the “suppression of that which is true, by one having knowledge or belief of the fact").
In
Shafer, supra,
See also
Pavicich v. Santucci
(2000)
While both parties refer to the consent form, it is not a part of the record in this case.
Jones Day cites several cases in connection with its statement that Vega could have discovered, with reasonable diligence, the “toxic” provisions of the financing. These cases reject fraudulent concealment claims where the information in question was readily accessible, or plaintiff was on inquiry notice of the allegedly concealed information. (E.g.,
Stevenson v. Baum
(1998)
The trial court stated it was “willing to sustain [the demurrer] without leave to amend and just get this on the short track up to the court of appeal,” although its general practice was to “give the other side a chance to amend if they think they can amend to cure the defect in the complaint. Q[] So it is up to you [Vega].” Vega’s counsel responded, “Well, if the reason for the demurrer sustaining it without leave to amend is that the court feels that there is somehow a different duty vis-a-vis Jоnes, Day as there is with Transmedia.” The court replied, “Well, that is one of the reasons.” Counsel then said, “All right. Then I think it is better to take it up now. I don’t want to fight Gibson, Dunn for a year and then be back here.”
Jones Day relies on
Nelson v. Anderson
(1999)
Since Vega’s negligent misrepresentation claim has been disposed of on other grounds (see fn. 6, ante), we need not consider whether it is governed by and barred by a shorter statute of limitations.
“ ‘Where no duty is imposed by law upon a person to make inquiry, and where under the circumstances “a prudent man” would not be put upon inquiry, the mere fact that means of knowledge are open to a plaintiff, and he has not availed himself of them, does not debar him from relief when thereafter he shall make actual discovery. The circumstances must be such that the inquiry becomes a duty, and the failure to make it a negligent omission.’ ”
(Hobart v. Hobart Estate Co., supra,
